Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 56; no. 3; pp. 692 - 695
Main Authors Schetelig, Johannes, Hoek, Jennifer, Stilgenbauer, Stephan, Middeke, Jan Moritz, Andersen, Niels Smedegaard, Fox, Christopher P., Lenhoff, Stig, Volin, Liisa, Shimoni, Avichai, Schroyens, Wilfried, van Gelder, Michel, Bunjes, Donald, van Biezen, Anja, Baldauf, Henning, de Wreede, Liesbeth C., Tournilhac, Olivier, Kröger, Nicolaus, Yakoub-Agha, Ibrahim, Dreger, Peter
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2021
Nature Publishing Group
Subjects
692/699/1541/1990/283/1895
692/700/565/2319
Care and treatment
Cell Biology
Chronic lymphocytic leukemia
Correspondence
Genetic aspects
Hematology
Hematopoietic Stem Cell Transplantation
Hematopoietic stem cells
Homografts
Human health and pathology
Humans
Internal Medicine
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell - genetics
Leukemia, Lymphocytic, Chronic, B-Cell - therapy
Life Sciences
Lymphatic leukemia
Medicine
Medicine & Public Health
Patient outcomes
Prospective Studies
Public Health
Stem Cells
Transplantation
Transplantation, Homologous
Tumor proteins
Tumor Suppressor Protein p53 - genetics
Europe
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Undefined-2
PMCID: PMC8589674
ISSN:0268-3369
1476-5365
DOI:10.1038/s41409-020-01013-y